个人简介

2006-2010        B.S., Soochow University, School of Life Sciences

2010-2015        Ph.D., Soochow University, Institute of Functional Nano & Soft Materials (FUNSOM)

2015-2018        Postdoctoral Researcher, University of North Carolina at Chapel Hill & North Carolina State                             University, Dept. of Joint Department of Biomedical Engineering
2018-present    Professor, Soochow University, 
FUNSOM


研究领域

Welcome to the Prof. Chao Wang's Group in the FUNSOM at Soochow University! The overall goal of our BIE Lab (Laboratory for Biomaterial and ImmunoEngineering, 生物材料与免疫工程实验室) is to integrate Biomaterials, Immunoengineering and Translational Medicine for the clinical applications. Our lab current research focuses include development of biomaterials for immunoengineering and immunotherapy, in order to develop effective novel immunotherapies for cancer, infectious diseases, autoimmune disorders and age-related disease. more>>

基本信息

头像

汪超  

职称:   教授

院部/部门:   功能纳米与软物质研究院

学历:  

学位:   Ph.D.

毕业学校:  

毕业专业:  

联系方式

通讯地址:  

邮政编码:  

电子邮箱:   cwang(at)suda.edu.cn

联系电话:   0512-65880722

传真号码:  

办公地点:   功能纳米与软物质研究院 910-408A

Copyright © 2011-2014苏州大学版权所有 苏州大学信息化建设与管理中心技术支持

科学研究

Biomaterials for Immunotherapy

The immune system is one of systemic barriers to the body’s defense against tumors. Emerging interest is moving on tilizing biomaterials for immunotherapy and immunoengineering of cancer therapy. Such biomaterial platform offers the remarkable ability to codelivery of multiple cargoes, control their release behavior, alter their kinetics and pharmacodynamic effects, and so on. In addition, well-designed functional biomaterials can alter the immune-related microenvironment, modulate the immune response, as well as reverse immunosuppressive tumor environment in the context of disease treatment.

Cell-based therapy

Various types of cells are promising drug carriers or living drugs themselves. Armed with the emerging techniques in materials science, molecular pharmaceutics and nanobiotechnology, cell engineering is an appealing therapeutic platform for the development of next-generation medications. We will study the enhanced therapy effects by the combination of functional cells and biomaterials. Generally, our biomaterials – based on micor/nanoparticles or scaffolds – will be engineered for switching using innovate and modern concepts in cell based therapy.


Immunity in Tumor Microenvironment

We will study the immune cells in the tumor microenvironment and the mechanisms of tumor to suppress the immune response. Understanding the mechanism by which the tumor microenvironment context is extremely important for the design of novel immunotherapies .


科研团队




Gallery

2021 autumn, bowling alley





2021 spring, Zhuhai 32nd CCS conference



2020 summer, Suzhou Amusement Land  retreat


2019 spring, Qiandao Lake retreat




Copyright © 2011-2014苏州大学版权所有 苏州大学信息化建设与管理中心技术支持

论文

First/corresponding author papers (View All Publications)



2022

[53] Huajian Shan#, Xuanfang Zhou#, Bo Tian, Chenyu Zhou, Xiang Gao, Chaowen Bai, Bingchen Shan, Yingzi Zhang, Shengxuan Sun, Dongdong Sun*, Qin Fan, Xiaozhong Zhou*, Chao Wang*, Jinyu Bai* Gold nanorods modified by endogenous protein with light-irradiation enhance bone repair via multiple osteogenic signal pathways. Biomaterials 284, 121482 (2022)

[52] Huan He#, Ziying Fei#, Tailin Guo, Yue Hou, Da Li, Kefeng Wang, Fuzeng Ren, Kelong Fan, Daijun Zhou, Chaoming Xie*, Chao Wang*, Xiong Lu* Bioadhesive injectable hydrogel with phenolic carbon quantum dot supported Pd single atom nanozymes as a localized immunomodulation niche for cancer catalytic immunotherapy. Biomaterials, 280, 121272, (2022) Link

[51] Jialu Xu, Qingle Ma, Yue Zhang, Ziying Fei, Yifei Sun, Qin Fan, Bo Liu, Jinyu Bai, Yue Yu, Jianhong Chu*, Jingrun Chen*, Chao Wang*Yeast-derived nanoparticles remodel the immunosuppressive microenvironment in tumor and tumor-draining lymph nodes to suppress tumor growth. Nature Communications, 13, 110 (2022) Link

[50] Huaxing Dai, Qin Fan, Ziying Fei, Qingle Ma, Qianyu Yang, Jiacheng Chu, Xuanfang Zhou, Yue Zhang, Ziliang Dong, Fang Xu, Beilei Wang, Rong Sun, Yifan Shen, Ruao Xie, Ruibin Li and Chao Wang*. Systemically Administered Silica Nanoparticles Result in Diminished T Cell Response in Lung. Nano Today 42, 101332 (2022) Link

[49] Qin Fan#, Huaxing Dai#, Jinyu Bai#, Jialu Xu, Qingle Ma, Ziying Fei, Xiaozhong Zhou*, Kam W. Leong*, Chao Wang*. Degradation-resistant Implanted Biomaterials Establish an Immunosuppressive Microenvironment that Induces T Cell Exhaustion by Recruiting Myeloid Cells. Fundamental Research (2022) Link

[48] Fang Xu, Ziying Fei, Huaxing Dai, Jialu Xu, Qin Fan, Shufang Shen, Yue Zhang, Qingle Ma, Jiacheng Chu, Fei Peng, Fangfang Zhou, Zhuang Liu, Chao Wang*. Mesenchymal Stem Cell-derived Extracellular Vesicles with High PD-L1 Expression for Autoimmune Diseases Treatment. Advanced Materials, 34, 2106265 (2022) Link

  


[47] Jiacheng Chu, Chenya Wang, Qingle Ma, Huaxing Dai, Jialu Xu, Edikan A. Ogunnaike, Fei Peng, Xiaolin Shi, Chao Wang*. Coupling PD-1+ Tumor-Infiltrating T Cells with anti-PD-1 Antibody Improve the Efficacy of Adoptive T-cell Therapy. Cytotherapy, 24, 291  (2022) Link


2021


[46] Hao Chen, Bo Tian, Xiyao Fang, Jinyu Bai, Qingle Ma, Yue Zhang, Jialu Xu, Beilei Wang, Qin Fan, Ziying Fei, Huaxing Dai, Huajian Shan, Xiang Gao, Qirong Dong, Chao Wang*, Xiaozhong Zhou*. Injectable Erythrocyte Gel Loaded with Bulleyaconitine A for the Treatment of Rheumatoid Arthritis, ACS Biomaterials Science & Engineering 7, 5706  (2021) Link

[45] Yue Zhang, Jialu Xu, Ziying Fei, Huaxing Dai, Qin Fan, Qianyu Yang, Yitong Chen, Beilei Wang, Chao Wang*. 3D Printing Scaffold Vaccine for Antitumor Immunity. Advanced Materials, 33, 2106768 (2021) Link



[44] Qingle Ma#, Jinyu Bai#, Jialu Xu, Huaxing Dai, Qin Fan, Ziying Fei, Jiacheng Chu, Chenlu Yao, Haoliang Shi, Xiaozhong Zhou*, Lin Bo*, Chao Wang*. Reshaping the Inflammatory Environment in Rheumatoid Arthritis Joints by Targeting Delivery of Berberine with Platelet‐Derived Extracellular Vesicles. Advanced NanoBiomed Research, 1,  2100071 (2021) Link

[43] Qingle Ma,‡ Chenlu Yao,‡  Haoliang Shi,‡ Jialu Xu, Huaxing Dai, Ziying Fei, Yi Wu, Ting Lu* and  Chao Wang*. Targeted Delivery of Dexamethasone in Acute Pneumonia. Biomaterials Science, 9, 5569 (2021)  Link

[42] Shufang Shen, Huaxing Dai, Ziying Fei, Yu Chai, Yu Hao, Qin Fan, Ziliang Dong, Yujie Zhu, Jialu Xu, Qingle Ma, Xiao Han, Ligeng Xu, Fei Peng, Zhuang Liu, Chao Wang*. Immunosuppressive Nanoparticles for Management of Immune-Related Adverse Events in Liver. ACS Nano, 5, 9111 (2021). Link


[41] Qin Fan, Jinyu Bai, Huajian Shan, Ziying Fei, Hao Chen, Jialu Xu, Qingle Ma, Xiaozhong Zhou* and Chao Wang*. Implantable Blood Clot Loaded with BMP-2 for Regulation of Osteoimmunology and Enhancement of Bone Repair. Bioactive Materials, 6, 4014 (2021). Link



[40] Yufen Xiao,Jun Chen*, Chao Wang*, Jianxun Ding*, Wei Tao*. Emerging Micro- and Nanotechnologies for Medical and Pharmacological Applications. Front. Pharmacol., 12, 648749 (2021). (Editorial) Link 

[39] Ziying Fei, Qin Fan*, Huaxing Dai, Xuanfang Zhou, Jialu Xu, Qingle Ma, Atsushi Maruyama*, Chao Wang*. Physiologically Triggered Injectable Red Blood Cell-Based Gel for Tumor Photoablation and Enhanced Cancer Immunotherapy. Biomaterials, 271, 120724 (2021). Link

[38] Qingle Ma, Qin Fan, Xiao Han, Ziliang Dong, Jialu Xu, Jinyu Bai, Weiwei Tao, Dongdong Sun* and Chao Wang*. Platelet-Derived Extracellular Vesicles to Target Plaque Inflammation for Effective Anti-atherosclerotic Therapy. Journal of Controlled Release, 329, 445 (2021). Link

[37] Jialu Xu and Chao Wang*. Cell-derived Vesicles for Delivery of Cancer Immunotherapy. Exploration of Medicine, 2, 39 (2021). (Invited Review) Link


2020

[36] Qin Fan, Qingle Ma, Jinyu Bai, Jialu Xu, Ziying Fei, Ziliang Dong, Atsushi Maruyama, Kam W. Leong, Zhuang Liu and Chao Wang*. An Implantable Blood Clot-based Immune Niche for Enhanced Cancer Vaccination. Science Advances, 6, eabb4639 (2020). Link[Biotechscope]


[35] Qingle Ma, Qin Fan, Jialu Xu, Jinyu Bai, Xiao Han, Ziliang Dong, Xiaozhong Zhou, Zhuang Liu, Zhen Gu* and Chao Wang*Calming Cytokine Storm in Pneumonia by Targeted Delivery of TPCA-1 Using Platelet-derived Extracellular Vesicles. Matter, 3, 287 (2020). LinkHighlight by [Matter]


[34] Lulu Cai#, Jialu Xu#, Zhenglin Yang, Rongsheng Tong, Ziliang Dong, Chao Wang* and Kam W. Leong*. Engineered Biomaterials for Cancer Immunotherapy. MedComm, Link (Invited review)

[33] Xuanfang Zhou, Zhouqi Meng*, Jialin She, Yaojia Zhang, Xuan Yi, Hailin Zhou, Jing Zhong, Ziliang Dong, Xiao Han, Muchao Chen, Qin Fan, Kai Yang and Chao Wang* . Near-Infrared Light-Responsive Nitric Oxide Delivery Platform for Enhanced Radioimmunotherapy. Nano-Micro Letters, 12, 100 (2020).

[32] Yingjun Liu, Dongdong Sun, Qin Fan, Qingle Ma, Ziliang Dong, Weiwei Tao, Huiquan Tao, Zhuang Liu and Chao Wang*. The Enhanced Permeability and Retention Effect based Nanomedicine at the Site of Injury. Nano Research, 13, 564-569 (2020).


2019

[31] 范亲汪超*.纳米材料在肿瘤免疫治疗中的应用.中国科学-生命科学, (2019). DOI:10.1360/SSV-2019-0215 (Invited review)

[30] Lin Zhang, Jinhua Zhou, Lvzhong Hu, Xiao Han, Xinwei Zou, Qian Chen, Youguo Chen*, Zhuang Liu*, Chao Wang*. In Situ Formed Fibrin Scaffold with Cyclophosphamide to Synergize with Immune Checkpoint Blockade for Inhibition of  Cancer Recurrence after Surgery. Advanced Functional Materials, 1906922 (2019). 

[29] Baowen Qi, Chao Wang*, Jianxun Ding* and Wei Tao*. Applications of Nanobiotechnology in Pharmacology. Frontiers in Pharmacology, 10, 1451 (2019). (Editorial)

[28] Jinyu Bai,Yingzi Zhang, Qin Fan, Jialu Xu, Huajian Shan, Xiang Gao, Qinle Ma, Lei Sheng, Xin Zheng, Weinan Chen, Dazhuang Li, Mingchao Zhang, Yu Hao, Liangzhu Feng, Qian Chen, Xiaozhong Zhou* and Chao Wang*. Reactive Oxygen Species-Scavenging Scaffold with Rapamycin for Treatment of Intervertebral Disc Degeneration. Advanced Healthcare Materials, 1901186 (2019).

[27] Xiao Han, Rui Wang, Jun Xu, Qian Chen, Chao Liang, Jiawen Chen, Jiayue Zhao, Jiacheng Chu, Qin Fan, Edikan Archibong, Lixin Jiang*, Chao Wang*, Zhuang Liu*. In situ thermal ablation of tumors in combination with nano-adjuvant and immune checkpoint blockade to inhibit cancer metastasis and recurrence. Biomaterials, 119490 (2019). 

[26] Xiao Han#, Shufang Shen#, Qin Fan, Guojun Chen, Edikan Archibong, Gianpietro Dotti, Zhuang Liu*, Zhen Gu* and Chao Wang*. Red Blood Cell Derived Nanoerythrosome for Antigen Delivery with Enhanced Cancer Immunotherapy. Science Advances, 5, eaaw6870 (2019).


[25] Xiao Han#, Jiawen Chen#, Jiacheng Chu, Chao Liang, Qingle Ma, Qin Fan, Zhuang Liu* and Chao Wang*. Platelets as Platforms for Inhibition of Tumor Recurrence Post-Physical Therapy by Delivery of anti-PD-L1 Checkpoint Antibody. Journal of Controlled Release, 304, 233-241(2019).


2018

[24] Xiaowen Liu, Chao Wang*, Zhuang Liu*. ProteinEngineered Biomaterials for CancerTheranostics. Advanced Healthcare Materials1800913(2018). (Review paper)

[23] Qin Fan, Zhipeng Chen,Chao Wang*, Zhuang Liu*. Toward Biomaterials for Enhancing Immune Checkpoint BlockadeTherapy. Advanced Functional Materials, 1802540 (2018). (Review paper)

[22] Xiao Han, Chao Wang*, Zhuang Liu *. Red Blood Cells as Smart Delivery Systems. Bioconjug Chem 29,852-860 (2018). (Review paper)

[21]Shuangjiang Yu#, Chao Wang#, Jicheng Yu, Jinqiang Wang, Yue Lu,Yuqi Zhang, Xudong Zhang, Quanyin Hu, Wujin Sun, Chaoliang He*, Xuesi Chen*, Zhen Gu*. Injectable Bioresponsive Gel Depot for Enhanced Immune CheckpointBlockade. Advanced Materials 1801527 (2018).

[20] Chao Wang#, Jinqiang Wang#, Xudong Zhang, Shuangjiang Yu, Di Wen, Quan Hu, Yanqi Ye, H.Bomba, X. Hu, Z. Liu. Gianpietro Dotti and Zhen Gu*. In situ formed reactiveoxygen species–responsive scaffold with gemcitabine and checkpoint inhibitorfor combination therapy. Science Translational Medicine 10,eaan3682 (2018).



2011-2017

[19] Chao Wang, Wujin Sun, Yanqi Ye, Hunter N Bomba, Zhen Gu*. Bioengineering of Artificial Antigen Presenting Cells and Lymphoid Organs. Theranostics 7, 3504-3516 (2017). (Review paper)

[18] Chao Wang, Wujin Sun, Yanqi Ye, Quanyin Hu, Hunter N Bomba, Zhen Gu*. In situ activation of platelets with checkpoint inhibitors for post-surgical cancer immunotherapy. Nature Biomedical Engineering 1, 0011 (2017).

[17] Chao Wang, Di Wen, Zhen Gu*. Cellular Bioparticulates with Therapeutics for Cancer Immunotherapy. Bioconjugate Chemistry, doi:10.1021/acs.bioconjchem.7b00619 (2017). (Review paper)

[16] Chao Wang, Yanqi Ye, Zhen Gu*. Local delivery of checkpoints antibodies. Human Vaccines & Immunotherapeutics 13, 245-248 (2017). (Review paper)

[15] Chao Wang, Yanqi Ye, Quanyin Hu, Adriano Bellotti, Zhen Gu*. Tailoring Biomaterials for Cancer Immunotherapy: Emerging Trends and Future Outlook. Advanced Materials 29, 201606036 (2017). (Review paper)

[14] Chao Wang, Yanqi Ye, Wujin Sun, Jicheng Yu, Jingqiang Wang, David S Lawrence, John B Buse, Zhen Gu*. Red Blood Cells for Glucose-Responsive Insulin Delivery. Advanced Materials 29, 201606617 (2017).

[13] Chao Wang#, Yanqi Ye#, Gabrielle M Hochu, Hasan Sadeghifar, Zhen Gu*. Enhanced Cancer Immunotherapy by Microneedle Patch-Assisted Delivery of Anti-{PD}1 Antibody. Nano Letters 16, 2334-2340 (2016).

[12] Chao Wang#, Min Ye#, Liang Cheng, Rui Li, Wenwen Zhu, Zhen Shi, Chunhai Fan, Jinkang He, Jian Liu, Zhuang Liu*. Simultaneous isolation and detection of circulating tumor cells with a microfluidic silicon-nanowire-array integrated with magnetic upconversion nanoprobes. Biomaterials 54, 55-62 (2015).

[11] Chao Wang, Xiaoqi Sun, Liang Cheng, Shengnan Yin, Guangbao Yang, Yonggang Li, Zhuang Liu*. Multifunctional Theranostic Red Blood Cells For Magnetic-Field-Enhanced in vivo Combination Therapy of Cancer. Advanced Materials 26, 4794-4802 (2014).

[10] Chao Wang, Ligeng Xu, Chao Liang, Jian Xiang, Rui Peng, Zhuang Liu*. Immunological Responses Triggered by Photothermal Therapy with Carbon Nanotubes in Combination with Anti-{CTLA}-4 Therapy to Inhibit Cancer Metastasis. Advanced Materials 26, 8154-8162 (2014).

[9] Liang Cheng#, Chao Wang#, Xinxing Ma, Qinglong Wang, Yao Cheng, Han Wang, Yonggang Li, Zhuang Liu*. Multifunctional Upconversion Nanoparticles for Dual-Modal Imaging-Guided Stem Cell Therapy under Remote Magnetic Control. Advanced Functional Materials 23, 272-280 (2013).

[8] Chao Wang, Liang Cheng, Yumeng Liu, Xiaojing Wang, Xinxing Ma, Zhaoyi Deng, Yonggang Li, Zhuang Liu*. Imaging-Guided pH-Sensitive Photodynamic Therapy Using Charge Reversible Upconversion Nanoparticles under Near-Infrared Light. Advanced Functional Materials 23, 3077-3086 (2013).

[7] Chao Wang, Liang Cheng, Zhuang Liu*. Upconversion Nanoparticles for Photodynamic Therapy and Other Cancer Therapeutics. Theranostics 3, 317-330 (2013). (Review paper)

[6] Chao Wang#, Huan Xu#, Chao Liang, Yumeng Liu, Zhiwei Li, Guangbao Yang, Liang Cheng, Yonggang Li, Zhuang Liu*. Iron Oxide @ Polypyrrole Nanoparticles as a Multifunctional Drug Carrier for Remotely Controlled Cancer Therapy with Synergistic Antitumor Effect. ACS Nano 7, 6782-6795 (2013).

[5] Chao Wang, Liang Cheng, Huan Xu, Zhuang Liu*. Towards whole-body imaging at the single cell level using ultra-sensitive stem cell labeling with oligo-arginine modified upconversion nanoparticles. Biomaterials 33, 4872-4881 (2012).

[4] Chao Wang, Xinxing Ma, Shuoqi Ye, Liang Cheng, Kai Yang, Liang Guo, Changhui Li, Yonggang Li, Zhuang Liu*. Protamine Functionalized Single-Walled Carbon Nanotubes for Stem Cell Labeling and In Vivo Raman/Magnetic Resonance/Photoacoustic Triple-Modal Imaging. Advanced Functional Materials 22, 2363-2375 (2012).

[3] Chao Wang, Liang Cheng and Zhuang Liu*. Research Spotlight: Upconversion nanoparticles for potential cancer theranostics. Therapeutic Delivery 2, 1235-1239 (2011). (Review paper)

[2] Chao Wang, Huiquan Tao, Liang Cheng and Zhuang Liu*. Near-infrared light induced in vivo photodynamic therapy of cancer based on upconversion nanoparticles. Biomaterials 32, 6145-6154 (2011).

[1] Chao Wang, Liang Cheng and Zhuang Liu*. Drug delivery with upconversion nanoparticles for multi-functional targeted cancer cell imaging and therapy. Biomaterials 32, 1110-1120  (2011).



Book chapter


[1] Shufang Shen and Chao Wang* (2020) Upconversion Fluorescent Nanoprobe for Highly Sensitive In Vivo Cell Tracking. Cell Tracking. Methods in Molecular Biology, vol 2126. Humana, New York, NY 




荣誉奖励

  • 1、Innovators Under 35 (TR35) Asia Pacific (MIT Technology Review),2021
  • 2、Highly Cited Researchers (Clarivate Analytics),2018-2020
  • 3、基金委“优秀青年基金”获得者,2020
  • 4、江苏省“双创”团队核心成员 ,2020
  • 5、CASNN Rising Star Award ,2019
  • 6、江苏省“双创”人才,2019
  • 7、江苏省“六大人才高峰”高层次人才 ,2019
  • 8、江苏省科学技术一等奖(第四完成人),2017
  • 9、Biomaterials Future Scientist Award ,2017
  • 10、教育部高等学校科学研究优秀成果自然科学奖二等奖(第四完成人),2014
Copyright © 2011-2014苏州大学版权所有 苏州大学信息化建设与管理中心技术支持

开授课程

  • 1、普通生物学,2019.12.31-,0,54
  • 2、普通生物学,2019.12.31-,0,54
  • 3、普通生物学,2019.12.31-,0,54
  • 4、普通生物学,,纳米材料与技术纳米医学,,2021.01.04-,0,54
  • 5、普通生物学,,纳米材料与技术纳米材料科学与工程,,2021.01.04-,0,54
  • 6、普通生物学,,纳米材料与技术纳米器件技术,,2021.01.04-,0,54

招生信息

苏州大学汪超教授课题组博士后研究人员招聘启事(2022)

 

  苏州大学拥有逾121年的悠久历史,坐落于素有“人间天堂”之称的历史文化名城苏州,是国家“双一流”建设高校、国家“211工程”和国家“2011计划”首批入列高校。本苏州大学纳米科学技术学院是国家教育部首批17所试点学院之一,材料科学与工程学科入选世界一流学科建设名单。

 

课题组简介

  汪超教授2010年本科毕业于苏州大学,2015年于苏州大学获得化学生物学博士学位。2015-2018年于美国北卡罗莱纳大学教堂山分校生物医学工程系担任博士后研究员。2018年获聘于苏州大学特聘教授。回国后组建“生物材料与免疫工程”实验室,独立开展科研工作。汪超教授是国家优秀青年基金获得者(2020)、2021MIT Technology Review TR35亚太区入选者、2018-2021 连续4年入选科睿唯安“全球高被引科学家”、曾获得江苏省科学技术一等奖(4/4)、教育部自然科学二等奖(4/5)等学术荣誉。主要在功能生物材料和免疫治疗前沿交叉领域从事研究,针对炎症、肿瘤、自身免疫性疾病的治疗需求,发展多种功能生物材料,在提高免疫治疗客观响应率和治疗效果、降低副作用方面开展了较为系统的工作,取得了具有一定国际影响力的研究成果。申请人在相关领域共发表学术论文93篇,申请人于2018年回国加入苏州大学后,以独立通讯或主通讯作者在包括Sci AdvNat CommunMatterAdv Mater等具有国际影响力的国内期刊以及业界公认的国际顶级或重要科技期刊上发表研究性论文20+篇,申请人论文总SCI他引19344次,H因子75,申请发明专利12项,目前授权5项。

 

本课题组科研氛围浓厚,积极向上,现因科研发展和教职空位填补需求,特向海内外诚聘优秀博士后研究人员。

 

博士后招聘方向(6人)

1. 工程化细胞外囊泡方向(2人)

2. 肿瘤免疫治疗应用方向(2人)

3. 免疫稳态研究方向(2人)

 

应聘条件

1. 具有科研创新能力和团队协作精神;

2. 具有熟练的实验研究技能;

3. 具有较好的中英文写作能力;

4. 以第一作者发表SCI二区文章2篇以上或领域顶级期刊1篇以上。

 

博士后待遇

1. 学校发放的三年总薪酬最高可超100万元:薪酬构成:20万元税前基本年薪ⅹ3+最高40万元绩效奖励;五险一金:学校按校内同类人员标准代为缴纳,不计入薪酬。

2. 在站期间,学校提供1.2万元/年的租房补贴,不计入薪酬。

3. 协助申报国家博士后创新人才支持计划(每人两年63万元)、江苏省卓越博士后资助计划(每人两年30万元)等各类人才项目以及各类研究基金项目(所获得的资助补贴不计入总薪酬,叠加发放)。

4. 根据科研贡献,同时享受院内科研奖励和组内科研奖励。

5. 协助联系赴国外(境外)大学或实验室从事合作研究。

6. 对于绩效评估优秀者,出站后可留组担任正式教职,也可优先推荐应聘校内教学科研岗位。

 

应聘材料

应聘者可将个人简历(学习、工作经历、研究背景、发表论文等详细材料),通过电子邮件方式发送 (主题请注明“应聘博士后-姓名”) 至邮箱cwang@suda.edu.cn。申请者一周内将收到邮件回复或电话面试。

 


Copyright © 2011-2014苏州大学版权所有 苏州大学信息化建设与管理中心技术支持